Skip to content
value.today

Integrated Endoscopy, Inc.

Total raised
$12 M
2 rounds on record
Latest round
$11 M
Sep 2018
First round on record
Dec 2016
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Integrated Endoscopy, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2018$11 MNo. 2$10 to $50 million

Integrated Endoscopy, Inc.: Raise no. 2, Sep 2018

Investors in this round

5 investors had bought by the notice of Sep 21, 2018: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $17 M offered; $6 M still to sell
Smallest investment taken
$25,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
$2,000,000
Paid to its own people
$1,000,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in California

People named in the notice

  • Brad Sharp · Executive Officer, Director
  • Gary Crane · Executive Officer
  • Laxmikant Khanolkar · Executive Officer
  • Robert Cripe · Executive Officer
  • Siddarth Desai · Executive Officer
  • Clay Daniells · Director
  • David Chou · Director
  • Hua Jianping · Director
  • Louis Luk · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Brillimed Group Limited · Chaoyang, Beijing, ChinaSold in no state named, and outside the US

Remarks in the notice

  • On the use of proceeds: “This amount will be paid as employee compensation to the executive officers throughout the first twelve months after the first closing.”

Signed by Brad Sharp, President. Source: SEC Form D, newest notice filed Sep 21, 2018. Read the notice at the SEC.

equity, optionsSEC
Dec 2016$1 MNo. 1Under $2 million

Integrated Endoscopy, Inc.: Raise no. 1, Dec 2016

Investors in this round

5 investors had bought by the notice of Jan 6, 2017: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $4 M offered; $3 M still to sell
Smallest investment taken
$50,000
What was sold
debt, options or other rights to buy securities, other: convertible promissory notes and warrants
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
$300,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in California

People named in the notice

  • Brad Sharp · Executive Officer, Director
  • Lonnie Hoyle · Executive Officer, Director
  • Martin Murphy · Executive Officer
  • Clay Daniells · Director
  • David Chou · Director
  • Louis Luk · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “This amount will be paid as employee compensation to the executive officers throughout the year.”

Signed by Brad Sharp, President. Source: SEC Form D, newest notice filed Jan 6, 2017. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Integrated Endoscopy, Inc. had revenue of up to $1 million when it filed its newest notice of a funding round (Sep 2018).

    SEC Form D (revenue range) · Sep 2018

  • Revenue range over time, as stated in its notices: no revenue in 2017; revenue of up to $1 million in 2018.

    SEC Form D (revenue range) · Sep 2018

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Sep 2018

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Integrated Endoscopy, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 5 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Integrated Endoscopy, Inc.
NameRoleNamed in
Brad SharpExecutive officerSep 2018
Gary CraneExecutive officerSep 2018
Laxmikant KhanolkarExecutive officerSep 2018
Robert CripeExecutive officerSep 2018
Siddarth DesaiExecutive officerSep 2018
Lonnie HoyleExecutive officerJan 2017
Martin MurphyExecutive officerJan 2017
Brad SharpDirectorSep 2018
Clay DaniellsDirectorSep 2018
David ChouDirectorSep 2018
Hua JianpingDirectorSep 2018
Louis LukDirectorSep 2018
Lonnie HoyleDirectorJan 2017